Please share! We've launched the 2025-2026 #endMS_SPRINT & 2025 #endMS_SummerSchool competitions! Inviting graduate students, post doctoral and clinical fellows, in MS research, to apply by Feb 19, 2025. For complete details: https://t.co/6MZt2Y0Ejm @ChristinaWolfs1 @MSCanada

Happy to present the 2024 endMS Spotlight on the Future newsletter with interviews from our graduating #SPRINT teams, a message from the 2025 #endMS_SummerSchool hosts & more! Please share! https://t.co/U9shn5xn2N @MSCanOfficial

Check out Rochelle’s new paper! She explored two drugs, #evobrutinib and #tolebrutinib outside of the context of B cells! Very important #neuroimmunology info off the heels of the very successful #HERCULES clinical trials in #multiplesclerosis #MS

@Craigurs @lameocampus @MemorialU @MUNMed

Hot off the press!!! Go take a look at my very first, “First Author” Manuscript🤓 We dive into how BTK inhibitors (tolebrutinib and evobrutinib) alter phenotype and function in human and mouse myeloid cells! So thankful for this publication🧠 https://t.co/EBVqiHaOWq

Our SPRINT interdisciplinary teams showcased their journey today, marked by hard work, learning, and fascinating outcomes. But beyond the results, it was wonderful to see the bonds forged, and the connections made! Great job teams! Very proud of you all!

A huge thank you to MS Canada for the Doctoral Studentship 2024-2025🧠👩🏻‍🔬Another big thank you to my supervisor @Craigurs as he always finds a way to support my ideas and my future endeavours! Congratulations to all the other receipts this year!!! @MSCanOfficial @MUNMed

Had an excellent time at the endMS conference in Toronto this week! So exciting to share some new data on how BTK inhibitors affect MS patient PBMCs! @MSCanOfficial @MemorialU @MUNMed

Day 1 of #MSMilan2023, so excited to see what’s in store this week! Even more grateful for @ECTRIMS to have accepted my abstract as a ePoster! Glad to be here and represent @MemorialU @MUNMed 🧠🤓

Come find me to chat about BTK inhibitors at 4:15pm 🤩 @ISNI_neuro @MSCanOfficial @MemorialU #weareneuroimmunology

Expanding a little beyond Multiple Sclerosis this week, with some incredible talks on other Neuroimmunological diseases, Psychoneuroimmunology, and Neuro-Oncology! @ISNI_neuro @MSCanOfficial @MemorialU #weareneuroimmunology

Please RT: This month's #endMS newsletter highlights the 2023 endMS Summer School, SPRINT teams, upcoming MS educational events, awards, funding opportunities, and more! View it here: https://t.co/OyGKJnFleb @ChristinaWolfs1 @MSCanOfficial

Look closely at these MRI scans. You’ll see PwMS portray their story in a unique and captivating way! Listen to their stories here: Manon: https://t.co/jtgE6ywzp8 Salima: https://t.co/9YjH6DfzS4 Patricia: https://t.co/7aTMlfBdsM #endMSSummerSchool @endMS

When your lab bestie needs one healthy control blood sample and you agree on the condition they photo document your macrophages 💁🏻‍♀️ @1998Rochelle

My first journal article was published almost 2 months ago 📑😄 Now that I’ve finally started using Twitter I can happily share it here! What a crazy, wonderful, exhausting experience - can’t wait for the next one! 🔬👩🏻‍🔬🤞 @mgrant_lab @MUNMed @RodRussell99

Please RT: This month's #endMS newsletter includes congrats to the successful Summer School and SPRINT applicants, upcoming MS related educational events, special announcements, publications, and more! View it here: https://t.co/OLSUFwAxTa @ChristinaWolfs1 @MSCanOfficial

Representing @MemorialU⁩ in San Diego this week ⁦@ACTRIMS⁩! So many incredible presentations and posters! Thankful for the opportunity and connections made 🧠

I got to discuss my research on Bruton Tyrosine Kinase Inhibiton in human and mouse myeloid cells @ECTRIMS this week! It was so refreshing to get others opinions and expertise! Looking forward to utilizing it in this project moving forward @MemorialU ! #endMS #BTKInhibitors

So real...

Every PhD student needs his motivational platypus #stateexamsoon #phdlife #PhDVoice